Bietti crystalline dystrophy complicated by choroidal neovascularization treated with a single dose of aflibercept
Oman Journal of Ophthalmology, cilt.16, sa.1, ss.142-144, 2023 (Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 16 Sayı: 1
- Basım Tarihi: 2023
- Doi Numarası: 10.4103/ojo.ojo_9_22
- Dergi Adı: Oman Journal of Ophthalmology
- Derginin Tarandığı İndeksler: Scopus, Academic Search Premier, Directory of Open Access Journals
- Sayfa Sayıları: ss.142-144
- Anahtar Kelimeler: Aflibercept, Bietti crystalline dystrophy, choroidal neovascularization, optical coherence tomography, retinal degenerations
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Bietti crystalline dystrophy is a rare hereditary autosomal recessive disease that causes photoreceptor loss secondary to degeneration of retinal pigment epithelium due to intracellular retinal pigment epithelial crystalline deposits and abnormal lipid metabolism. We aimed to present a case of choroidal neovascular membrane secondary to Bietti crystalline dystrophy diagnosed with multimodal imaging and treated with an intravitreal injection of aflibercept. A single dose of aflibercept injection might be effective due to its higher affinity for vascular endothelial growth factor (VEGF) in comparison with other anti-VEGFs. It might be a treatment alternative that can be considered in the choroidal neovascular membrane due to uncommon etiologies.